Dr. Reddys Laboratories Ltd.

BSE: 500124 | NSE: DRREDDY
Large Cap | Pharmaceuticals & Drugs
1175.55
-10.90 (-0.92%)
< Home < Back

Dr. Reddy’s Laboratories informs about asset purchase agreement of subsidiary company

Date: 17-12-2022

In compliance with Regulation 30 of SEBI Listing Regulations, Dr. Reddy’s Laboratories has informed that, Dr. Reddy's Research and Development B. V., a wholly owned subsidiary of the Company, has entered into an Asset Purchase Agreement for sale of its certain assets and liabilities including transfer of employees at site situated at Zernikedreef 12, 2333, CL Leiden, The Netherlands. The disclosure required under Regulation 30 of the SEBI Listing Regulations read with Circular is enclosed as Annexure-A.

The above information is a part of company’s filings submitted to BSE.